Medikabazaar hires former Regional HR Head of Reliance Jio Anil Mohanty

IMT News Desk
IMT News Desk
· 3 min read

Mumbai, September 13th, 2019: Continuing with its goal to provide robust tech-driven procurement efficiency solutions in the healthcare sector, Medikabazaar, India’s largest online B2B platform for medical supplies, has announced the appointment of Anil Mohanty. The hiring is in line with the company’s plans for rapid expansion, with a major focus on strengthening its leadership team while attracting and developing the best talent to support Medikabazaar’s growth strategy. With over two decades of experience across the HR segment such as workforce planning, succession planning, skill assessment, enhancement of performance, employee experience and employee recreation .Mr Mohanty will spearhead Medikabazaar’s overall HR strategy, performance and culture building. 

Anil is seasoned and senior HR personnel, having led several Human Resource portfolios at a number of prominent organisations across the country. Prior to joining Medikabazaar, he was last working with Reliance Jio since its inception as the head of HR for the northern region. Additionally, he has worked with organisations like Idea Cellular, Tata Teleservices, Huawei Telecommunication and Telenor India.

Speaking on Anil’s appointment, Vivek Tiwari, Founder, and CEO, Medikabazaar said, “We are glad to have Mr Anil Mohanty join our team as the Head of HR as his expertise would help us with our objective of hiring, preserving & developing the most suitable and talented personnel for a plethora of operations that help us evolve as India’s largest aggregator of medical B2B supplies. “

Commenting on the same, Anil Mohanty Head of HR, Medikabazaar said, “In a very short period, Medikabazaar has proved itself as a driving force responsible for revolutionising the Indian healthcare medical supplies procurement landscape. I am deeply honoured and touched to be a part of such an esteemed enterprise and am looking most forward to applying my skills and experience towards the expansion and growth of Medikabazaar. My aim is to enable a workplace for employees to dedicate their best toward the company’s aim of becoming the leading B2B platform for medical supplies, and a force to reckon with in the healthcare sector.”

Since its inception in 2015, Medikabazaar has emerged as a segment leader in the healthcare space. By eliminating the need for intermediaries, it aims at providing hospitals and healthcare facilities pan-India with the right facilities and equipment at the best price. The company’s approach focuses on extensive research on the needs of the Indian market, based on which it tailors its product and service offerings. Currently, Medikabazaar is focusing its efforts on raising funds for recruitment, expanding product categories and focusing on increased automation through leveraging new-age technologies. The hiring of Anil Mohanty is aimed at propelling the company’s HR strategy and exploring new avenues of growth and progress.

Read Next

Sun Pharma receives DCGI approval to manufacture, market generic semaglutide injection in India for chronic weight management
Corporate
January 27, 2026

Sun Pharma receives DCGI approval to manufacture, market generic semaglutide injection in India for chronic weight management

Company to launch product after the expiry of semaglutide patent in India Sun Pharmaceutical Industries has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic version of semaglutide injection. Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is indicated for chronic weight management in adults as an adjunct to […]
Article by: IMT News Desk
Lupin receives highest ESG rating from CDP for climate change and water security
Corporate
January 27, 2026

Lupin receives highest ESG rating from CDP for climate change and water security

The recognition affirms Lupin’s position among distinguished global leaders who champion sustainability and transparency at the highest level Lupin has received the highest ‘A’ leadership rating from Climate Disclosure Project (CDP) for its exceptional accomplishments in Climate Change and Water Security. The recognition affirms Lupin’s position among distinguished global leaders who champion sustainability and transparency […]
Article by: IMT News Desk
AstraZeneca Pharma India receives CDSCO approval for breast cancer drug
Corporate
December 19, 2025

AstraZeneca Pharma India receives CDSCO approval for breast cancer drug

Dato-DXd is a specifically engineered antibody drug conjugate that targets TROP2, a protein frequently overexpressed in breast cancer AstraZeneca Pharma India announced that the Central Drugs Standard Control Organisation (CDSCO) has granted regulatory approval to import, sell, and distribute Datopotamab Deruxtecan (Dato-DXd) in India. The approval reflects AstraZeneca’s focus on bringing to life-changing medicines at […]
Article by: IMT News Desk
Novo Nordisk launches Ozempic in India
Corporate
December 12, 2025

Novo Nordisk launches Ozempic in India

Ozempic is a once-weekly GLP-1 RA (receptor agonist) indicated as an adjunct to diet and exercise for adults living with uncontrolled type 2 diabetes mellitus Novo Nordisk announced the launch of Ozempic (injectable semaglutide) in India. Ozempic is a once-weekly GLP-1 RA (receptor agonist) indicated as an adjunct to diet and exercise for adults living […]
Article by: IMT News Desk